---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-058855"
form_type: "8-K"
ticker: null
cik: "0001907685"
company_name: "Comera Life Sciences Holdings, Inc."
filed_at: "2023-11-03T23:59:59+00:00"
generated_at: "2026-06-08T22:45:35.856322+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Comera receives Nasdaq delisting notice; expects to trade on OTC Markets

## Summary
- On Oct 31, 2023, Comera notified by Nasdaq of failure to cure $1.00 minimum bid price deficiency within 180-day period; not eligible for second period.
- Hearings panel to consider this deficiency; Company must submit written views by Nov 7, 2023.
- Previously, Nasdaq granted conditional continued listing until Nov 14, 2023, subject to meeting bid price and MVLS rules.
- Company believes it is unlikely to regain compliance by Nov 14; expects delisting and trading on OTC Markets.
- If delisted, Comera will remain an SEC reporting company under Exchange Act.

## SEC filing metadata
- accession: 0000950170-23-058855
- form_type: 8-K
- cik: 0001907685
- company_name: Comera Life Sciences Holdings, Inc.
- filed_at: 2023-11-03T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/0000950170-23-058855-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/cmra-20231031.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-058855
- JSON: https://secwatch.observer/filing/0000950170-23-058855.json
- Plain text: https://secwatch.observer/filing/0000950170-23-058855.txt

## Key facts
- Listing & Compliance Notices
  Comera Life Sciences Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5550(b)(2)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A), 5550(b)(2)
  source text: October 31, 2023, Comera Life Sciences Holdings, Inc. (the “Company”) received notice from The Nasdaq Stock Market LLC that the Company had not regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “bid price requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) within the 180 calendar day period provided by Rule 5810(c)(3)(A) and that the Company is not eligible for a second 180 day period to regain compliance. The notice letter indicated that the Nasdaq Hearings Panel will consider this matter in their decision regard
  evidence_url: https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/0000950170-23-058855-index.htm
- Listing & Compliance Notices
  Comera Life Sciences Holdings, Inc. received a nasdaq hearing update notice regarding market value (rules 5550(b)(2), 5550(a)(2), 5550(b)).
  - Exchange: nasdaq
  - Notice: hearing update
  - Deficiency: market value
  - Rules: 5550(b)(2), 5550(a)(2), 5550(b)
  source text: ”) received notice from The Nasdaq Stock Market LLC that the Company had not regained compliance with the $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market (the “bid price requirement”), as set forth in Nasdaq Listing Rule 5550(a)(2) within the 180 calendar day period provided by Rule 5810(c)(3)(A) and that the Company is not eligible for a second 180 day period to regain compliance.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1907685/000095017023058855/0000950170-23-058855-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.